GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) 3-Year Book Growth Rate : 1.40% (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria 3-Year Book Growth Rate?

GlaxoSmithKline Consumer Nigeria's Book Value per Share for the quarter that ended in Jun. 2023 was ₦7.71.

During the past 12 months, GlaxoSmithKline Consumer Nigeria's average Book Value per Share Growth Rate was -2.90% per year. During the past 3 years, the average Book Value per Share Growth Rate was 1.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was -7.70% per year. During the past 10 years, the average Book Value per Share Growth Rate was -3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 18.40% per year. The lowest was -19.00% per year. And the median was 1.70% per year.

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's 3-Year Book Growth Rate

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's 3-Year Book Growth Rate falls into.

GlaxoSmithKline Consumer Nigeria 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

GlaxoSmithKline Consumer Nigeria 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines